Speaker

Adams

David ADAMS, MD

Université Paris Saclay, France

Vittorio BELLOTTI, MD, PhD

University of Pavia

Julian GILLMORE, MD, PhD

National Amyloidosis Centre, University College London, London, United Kingdom

Suzanne LENTZSCH, MD, PhD

Columbia University New York

Marc RAAB, MD

University Hospital Heidelberg, Germany

Davide ROSSI, MD, PhD

Università della Svizzera Italiana, Bellinzona, Switzerland

Christophe SIRAC, PhD

University professor Team Biology of Plasma cells, Immunopathology and Cancer (BioPIC) CRIBL unit, CNRS UMR7276, INSERM U1262 University of Limoges and French National reference center for AL amyloidosis

Per WESTERMARK, MD

Department of Immunology, Genetics and Pathology, Uppsala Biomedical Cente, Sweden

Cornelia WEYAND, MD, PhD

Division of Immunology and Rheumatology, Department of Medicine, Stanford University, Stanford, CA, United States; Department of Medicine, Palo Alto Veterans Administration Healthcare System, Palo Alto, CA Division of Rheumatology, Department of Medicine, Mayo Clinic School of Medicine and Sciences, Rochester, MN, United States.